Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cristobal Augusto Frutos Ortiz"'
Autor:
Laurent Garderet, Luuk Gras, Linda Koster, Anita D'Souza, Noel Estrada-Merly, Parameswaran Hari, Wael Saber, Andrew J. Cowan, Minako Iida, Shinichiro Okamoto, Hiroyuki Takamatsu, Shohei Mizuno, Koji Kawamura, Yoshihisa Kodera, Nada Hamad, Bor-Sheng Ko, Christopher Liam, KIM Wah HO, A. Sim Goh, S. Keat Tan, Alaa M. Elhaddad, Ali Bazarbachi, Qamar un Nisa Chaudhry, Rozan Alfar, Mohamed-Amine Bekadja, Malek Benakli, Cristobal Augusto Frutos Ortiz, Eloisa Riva, Sebastian Galeano, Francisca Bass, Hira S. Mian, Arleigh McCurdy, Feng Rong Wang, Daniel Neumann, Mickey Koh, John A. Snowden, Stefan Schönland, Donal P. McLornan, Patrick John Hayden, Anna Sureda, Hildegard T. Greinix, Mahmoud Aljurf, Yoshiko Atsuta, Dietger Niederwieser
Publikováno v:
Blood. 140:4839-4842
Autor:
Cristobal Augusto Frutos Ortiz, Lidiane Andino, Alfredo Reinaldo Quiroz, Dietger Niederwieser, Maria Elvira Enciso, Aline Nicole Paats, Victor Salinas
Publikováno v:
Blood. 140:8936-8937
Autor:
Denisse Castro, Jorge J. Castillo, Ivan Perdomo, Efreen Montaño Figueroa, Cristobal Augusto Frutos Ortiz, Humberto Martínez Cordero, Mercedes Royg Arriola, Brady E Beltran, Alana Von Glasenapp, Gladys P. Agreda-Vásquez, Eduardo M. Sotomayor, Marcos Distefano, Guillermo J. Ruiz-Argüelles, Camila Peña, Katerine Garcia, Lidiane Andino, Lorena Fiad, Maria Elvira Enciso, Cristaldo Nancy, Carolina Feres, Maria Virginia Prates, Rosio Baena, Henry Idrobo, Sally Rose Paredes, Virginia Otero, Fabiola Valvert, Daniela Zambrano, Luis Villela Villela, Maria Elena Cabrera, Luis E Malpica Castillo, Alfredo Reinaldo Quiroz, Melani Otañez, Juan Ospina Idarraga, Myrna Candelaria, Juan Antonio Choque, Maria Alejandra Torres Viera, Magali DelosRios, Mariana Kalmus, Fernando Perez-Jacobo, Guilherme Fleury Perini, Ana Florencia Ramirez-Ibarguen, Julian Cordova, David Gómez-Almaguer, María Lorena Cardozo, Eloisa Riva
Publikováno v:
Blood. 136:25-27
Introduction. There are different scoring systems to differentiate risk groups in patients with DLBCL treated with chemoimmunotherapy. Those systems have used the same 5 variables (age, performance status, LDH, stage, extranodal involvement) for 27 y
Autor:
Helen Baldomero, Mahmoud Aljurf, Gregorio Jaimovich, Alaa Elhaddad, Nina Worel, Hildegard Greinix, Nicolaus Kröger, Nicolas Novitzky, Jeff Szer, Cristobal Augusto Frutos Ortiz, Juliana Martinez Rolon, Sebastian Galeano, Marcelo C. Pasquini, Yoshiko Atsuta, Mickey Koh, Daniel J. Weisdorf, Rolandas Gerbutavičius, Adriana Seber, Jakob Passweg, Nosa Bazuaye, Yoshihisa Kodera, Malek Benakli, Dietger Niederwieser
Publikováno v:
Blood. 134:2035-2035
HSCT is the only curative option for many malignant and non-malignant diseases. The WBMT was founded as an umbrella organization of societies involved in cellular therapies with the mission of promoting excellence in HSCT. As a non-governmental organ